UNDP charts a rights- and development-centred turn in drug policy, prioritising decriminalisation, harm reduction, equity-led transitions, and practical pathways to responsibly regulate some drug markets.
November 25 is the international day for elimination of violence against women. WHRIN's global campaign calls groups worldwide to join the 16 Days of Action with activities highlighting violence against women and gender diverse people who use drugs and demanding rights–based, gender-sensitive drug policies.
Zuluaga Duque et al. reveal how coca substitution policies continue to undermine women’s autonomy by overlooking their conditions of exploitation and exclusion despite their centrality in cultivation.
London-Nadeau et al. urge solidarity against authoritarian attacks on bodily autonomy, highlighting shared histories of resistance and how they gesture to collective liberation.
Against criminalisation, invisibility and systemic violence, these initiatives seek to expand gender-responsive harm reduction and policy reform, based on lived experience.
The Harm Reduction Coalition and the Academy of Perinatal Harm Reduction offer a toolkit to support the health and well-being of pregnant people who use drugs and their families.
The event will reflect on the historical exclusion of women and nonbinary people who use drugs from traditional feminist spaces and advocacy, and alternative and inclusive approaches through the prism of 'narcofeminism'.
Cuts in foreign aid and shrinking space for civil society are jeopardising decades of progress in harm reduction, gender equality, and sexual and reproductive health rights.
Zolopa et al. identify predictive factors of overdose requiring an emergency response at SIS in Montréal, including gender identity, age, housing status, and frequency and nature of use.
SWAN examines the social justice impact of intersecting identities and provides recommendations for improving services, rights-based programs, and advocacy.
